These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4662426)

  • 1. [Treatment of pulmonary tuberculosis by the one-time administration of preparations depending on the degree of isonicotinic acid hydrazide inactivation].
    Oliferovskaia RP
    Sov Med; 1972 Apr; 35(4):104-7. PubMed ID: 4662426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of the inactivation of isonicotinic acid hydroxide preparations in the combined treatment of pulmonary tuberculosis].
    Smirnov GA
    Sov Med; 1965 Apr; 28(4):64-71. PubMed ID: 5866345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
    Sosnowski W; Rozniecki J; Podoska M; Galamon T
    Gruzlica; 1970 Oct; 38(11):1089-95. PubMed ID: 4249764
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of ethivanamide combined with isonicotinic acid hydrazine in the intermittent treatment of pulmonary tuberculosis].
    Krawczyk Z; Ratajek M; Sosnowski W
    Gruzlica; 1975 Oct; 43(10):921-7. PubMed ID: 1181252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethambutol in association with isonicotinic acid hydrazide in the therapy of pulmonary tuberculosis primary infection. (Case reports and comparison with the association of streptomycin and isoniazid)].
    Briccarello L; Ferraro U; Vercellino E
    G Ital Mal Torace; 1968; 22(2):81-9. PubMed ID: 5704055
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in ECG following intravenous administration of isonicotinic acid hydrazide].
    Dettlaff Z
    Gruzlica; 1969 Aug; 37(8):767-71. PubMed ID: 5352303
    [No Abstract]   [Full Text] [Related]  

  • 12. [Content of pyridoxine (vitamin B6) in the body of patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide evaluated by means of the tryptophan test].
    Sosnowski W; Rózniecki J; Lowkis L; Galamon T
    Postepy Hig Med Dosw; 1968; 22(3):483-8. PubMed ID: 5669146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medullary aplasia after administration of isonicotinic acid hydrazide (INH)].
    Baran E; Berneagă O; Vacariu O; Tomoşoiu G
    Rev Med Chir Soc Med Nat Iasi; 1973; 77(3):607-12. PubMed ID: 4742729
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoprodian in ambulatory therapy of pulmonary tuberculosis].
    Opl G; Novak M
    Prax Klin Pneumol; 1980 Dec; 34(12):715-8. PubMed ID: 7465531
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of inactivation of phthivazid in the therapy of tuberculosis in children].
    Aminov NR
    Probl Tuberk; 1965; 43(8):29-33. PubMed ID: 5296614
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aerosol therapy of pulmonary tuberculosis with differing degrees of resistance to GINK preparations].
    Kulik NM
    Probl Tuberk; 1972; 50(11):78-9. PubMed ID: 4647624
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 20. [Difficulties in the treatment of pulmonary tuberculosis in a patient rapidly inactivating isoniazid (INH)].
    Bednarski Z
    Wiad Lek; 1984 Jun; 37(12):937-40. PubMed ID: 6523868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.